Patient Guide: Study of ARO-ANG3 in Participants With Homozygous Familial Hypercholesterolemia (HOFH)

Why Use Quri.ai for This Trial?

  • ✓ Simplified eligibility checker - know if you qualify in minutes
  • ✓ Direct contact with study coordinators at 7 locations
  • ✓ Plain language explanations of medical terms and procedures
  • ✓ Personalized enrollment support throughout your journey
  • ✓ Free service - no hidden fees or obligations
Trial ID: NCTNCT05217667
Status: ACTIVE_NOT_RECRUITING
Condition: Homozygous Familial Hypercholesterolemia
Phase: PHASE2

Where You Can Participate

This study is available at 7 locations across the country.

Top locations include:
  • • Mount Sinai, New York
  • • Cincinnati, Ohio
  • • Camperdown, New South Wales
  • • And 4 more locations

Loading interactive enrollment tools...

The full interactive experience will load momentarily

Study of ARO-ANG3 in Participants With Homozygous Familial Hypercholesterolemia (HOFH) - Join Clinical Trial NCTNCT05217667

How to Join This Clinical Trial - NCTNCT05217667

Learn how to participate in this PHASE2 trial studying an investigational therapy for Homozygous Familial Hypercholesterolemia. Current status: ACTIVE_NOT_RECRUITING.

Am I Eligible for This Clinical Trial?

This clinical research study is looking for participants with Homozygous Familial Hypercholesterolemia. Eligibility requirements include specific age ranges, health status, and medical history. Contact the study team to learn if you qualify.

Condition Being Studied
Homozygous Familial Hypercholesterolemia
Treatment Being Tested
Investigational treatment
Study Phase
PHASE2 - Safety and effectiveness study
Enrollment Status
ACTIVE_NOT_RECRUITING
Study Identifier
NCTNCT05217667 - ClinicalTrials.gov Identifier
Sponsored By
Study sponsor

What to Expect as a Participant

Participating in this clinical trial involves:

  • Initial screening to determine eligibility
  • Regular study visits and health assessments
  • Receiving the study treatment or placebo
  • Medical monitoring and follow-up care
  • Contributing to medical research that may help others
  • Potential access to new treatments before they're widely available

Clinical Trial Benefits and Compensation

Participants in this clinical research study may receive:

  • Close medical monitoring by healthcare professionals
  • Access to potential new treatments
  • Compensation for time and travel (varies by study)
  • No-cost study-related medical care
  • The opportunity to help advance medical knowledge

Where Is This Clinical Trial Located?

This study is enrolling participants at 7 locations. Find a study site near you:

Clinical Research Site

Mount Sinai, New York 10029 - United States

Status: Contact for availability

Clinical Research Site

Cincinnati, Ohio 45227 - United States

Status: Contact for availability

Clinical Research Site

Camperdown, New South Wales 2050 - Australia

Status: Contact for availability

Clinical Research Site

Nedlands, Western Australia 6009 - Australia

Status: Contact for availability

Clinical Research Site

Chicoutimi, Quebec G7H 7K9 - Canada

Status: Contact for availability

Clinical Research Site

Québec, Quebec G1V 4W2 - Canada

Status: Contact for availability

Clinical Research Site

Johannesburg, 2193 - South Africa

Status: Contact for availability

How to Enroll in This Study

To learn more about participating in this PHASE2 clinical trial for Homozygous Familial Hypercholesterolemia:

  1. Review the eligibility criteria with your healthcare provider
  2. Contact the study team for a pre-screening interview
  3. Schedule an in-person screening visit if eligible
  4. Review and sign the informed consent form
  5. Begin participation in the clinical trial

Why Choose Quri.ai Study Finder

Quri.ai's Study Finder is the leading clinical trial business intelligence platform, helping BD professionals:

  • Discover clinical trials before competitors
  • Access exclusive contact information
  • Track sponsor pipelines and opportunities
  • Connect with decision makers directly
  • Win more business partnerships